Comparative efficacy between atorvastatin and rosuvastatin in the prevention of cardiovascular disease recurrence

BACKGROUND: There is no randomized clinical trials with recurrence of atherosclerotic cardiovascular disease (ASCVD) as a major outcome with rosuvastatin. In order to analyze potential differences in the clinical response to atorvastatin and rosuvastatin in secondary ASCVD prevention, we have analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez-Calahorra, Sofía, Laclaustra, Martin, Marco-Benedi, Victoria, Pinto, Xavier, Sanchez-Hernandez, Rosa M., Plana, Núria, Ortega, Emilio, Fuentes, Francisco, Civeira, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905000/
https://www.ncbi.nlm.nih.gov/pubmed/31829197
http://dx.doi.org/10.1186/s12944-019-1153-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905000/
https://www.ncbi.nlm.nih.gov/pubmed/31829197
http://dx.doi.org/10.1186/s12944-019-1153-x

Ejemplares similares